Delivery Order SPE2DB22D3301-SPE2DB24FY6MP

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,477.36, is for the delivery of 4560955312 NAFTIN 1% GEL 40GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,471.98 Firm Fixed Price Delivery Order contract is for the medical product NAFTIN 1% GEL 40GM. The contract has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,125.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIN 2% GEL 45GM, a pharmaceutical product, and is a Firm Fixed Price Delivery Order. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,308.10 delivery order is for the supply of NAFTIN 2% Gel, a prescription topical antifungal medication, with a period of performance through May 2024. The contract has a firm fixed price pricing structure and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,622.52, is for the delivery of NAFTIN 2% GEL 60GM, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with a completion date of February 13, 2024. The contract has no set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug...
This federal contract award, valued at $5,108.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4563323990 - NAFTIN 1% GEL 40GM, a pharmaceutical product. The award has an ultimate completion date of January 16, 2024 and a firm fixed-price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,576.67 firm-fixed-price contract is for the supply of Naftin 2% gel, a topical antifungal medication. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical sourcing and distribution services company Amerisourcebergen Corporation. The $1,953.29 order is for the supply of NAFTIN 1% GEL 40GM, a pharmaceutical product, to support military treatment programs and facilities. No set-aside designation was used. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,129.11 firm fixed-price delivery order is for the supply of NAFTIFINE HCL 2% GEL 60GM, a topical antifungal medication. The contract has a period of performance through February 28, 2025 and is not associated with any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.43 Firm Fixed Price delivery order contract is for the supply of Naftifine HCL 2% Gel, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY6MP
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09, UEI: KABZK8W6PQT3) is for the supply of NAFTIN 1% GEL 40GM pharmaceutical products to the Defense Logistics Agency (DLA). The $17,759.35 firm fixed price delivery order has a completion date of May 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:39 PM